When 10-year-old Samuel Henderson decided to share his bird calls at a school talent show this past May, he wasn’t nervous at all. In fact, in his mind, he was playing to a much larger audience than ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. U.S. President ...

After Jesse Ridgway, a popular YouTuber, and his wife, Ashley, revealed the news, death threats followed. By Pooja Salhotra For more than a decade, Jesse Ridgway has made a living posting YouTube ...

Washington — President Trump on Friday told the Wall Street Journal that he wants Bill Pulte, his controversial pick to run the Office of the Director of National Intelligence, to "start the process" ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

The artificial intelligence giant said a “brake pedal” was needed to protect humanity from self-improving models. The proposal could have big consequences. By Andrew Ross Sorkin Bernhard Warner Sarah ...

Anthropic said its powerful new AI model, Mythos, could be dangerous in the wrong hands. WSJ’s Nicole Nguyen explains why and shares some cybersecurity tips for the average tech user. Photo: Sean ...

Anthropic says AI could soon improve without human intervention Development pause will allow society to deal with AI's implications, startup says Previous attempts to halt AI progress have not been ...

The couple shared on their Instagram Stories that Jesse's wife Ashley got an abortion earlier this week Jesse Ridgway/Instagram Jesse acknowledged that some fans might be "very disappointed" by the ...

Claude now authors over 80% of the code Anthropic merges into production. Engineers shipped 8 times as much code per day in 2026 as in 2024. On a code-speedup test Claude hit 52x, versus 4x for ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...